These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18839123)

  • 1. [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].
    Kompardt J; Schärff K; Kubosch K; Pohl C; Bomplitz M; Soukup J
    Anaesthesist; 2008 Dec; 57(12):1201-9. PubMed ID: 18839123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A technical review of the history, development and performance of the anaesthetic conserving device "AnaConDa" for delivering volatile anaesthetic in intensive and post-operative critical care.
    Farrell R; Oomen G; Carey P
    J Clin Monit Comput; 2018 Aug; 32(4):595-604. PubMed ID: 29388094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncontrolled delivery of liquid volatile anaesthetic when using the anaesthetic conserving device.
    Karnjuš I; Mekiš D; Križmarić M
    J Clin Monit Comput; 2018 Aug; 32(4):629-638. PubMed ID: 28567612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation].
    Meiser A; Bellgardt M; Vogelsang H; Sirtl C; Weber T
    Anaesthesist; 2010 Nov; 59(11):1029-40. PubMed ID: 20878139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art: sedation concepts with volatile anesthetics in critically Ill patients.
    Soukup J; Schärff K; Kubosch K; Pohl C; Bomplitz M; Kompardt J
    J Crit Care; 2009 Dec; 24(4):535-44. PubMed ID: 19327951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit.
    Meiser A; Laubenthal H
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):523-38. PubMed ID: 16013698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient application of volatile anaesthetics: total rebreathing or specific reflection?
    Bomberg H; Volk T; Groesdonk HV; Meiser A
    J Clin Monit Comput; 2018 Aug; 32(4):615-622. PubMed ID: 29302897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance.
    Pruski M; O'Connell S; Knight L; Morris R
    Appl Health Econ Health Policy; 2024 Nov; 22(6):805-813. PubMed ID: 39060904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AnaConDa as last resort treatment. Case report of a chronic obstructive pulmonary disease].
    Nickel EA; Benken I; Bartels U; Voelckel WG; Quintel M
    Anaesthesist; 2007 Jun; 56(6):587-91. PubMed ID: 17375268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health worker exposure risk during inhalation sedation with sevoflurane using the (AnaConDa®) anaesthetic conserving device.
    González-Rodríguez R; Muñoz Martínez A; Galan Serrano J; Moral García MV
    Rev Esp Anestesiol Reanim; 2014 Mar; 61(3):133-9. PubMed ID: 24439525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of PICU sedation with isoflurane delivered by the 'AnaConDa'.
    Sackey PV; Martling CR; Radell PJ
    Paediatr Anaesth; 2005 Oct; 15(10):879-85. PubMed ID: 16176317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wash-in kinetics for sevoflurane using a disposable delivery system (AnaConDa) in cardiac surgery patients.
    Sturesson LW; Johansson A; Bodelsson M; Malmkvist G
    Br J Anaesth; 2009 Apr; 102(4):470-6. PubMed ID: 19244261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report.
    Pickworth T; Jerath A; DeVine R; Kherani N; Wąsowicz M
    Can J Anaesth; 2013 Jan; 60(1):38-43. PubMed ID: 23132045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa(®) device.
    Misra S; Koshy T
    Indian J Anaesth; 2012 Nov; 56(6):518-23. PubMed ID: 23325934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AnaConDa reflection filter: bench and patient evaluation of safety and volatile anesthetic conservation.
    Berton J; Sargentini C; Nguyen JL; Belii A; Beydon L
    Anesth Analg; 2007 Jan; 104(1):130-4. PubMed ID: 17179257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New technical developments for inhaled sedation].
    Meiser A; Bomberg H; Volk T; Groesdonk HV
    Anaesthesist; 2017 Apr; 66(4):274-282. PubMed ID: 28144686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care nurses' experiences using volatile anaesthetics in the intensive care unit: An exploratory study.
    Olsby JH; Dihle A; Hofsø K; Steindal SA
    Intensive Crit Care Nurs; 2022 Jun; 70():103220. PubMed ID: 35216899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing charcoal and zeolite reflection filters for volatile anaesthetics: A laboratory evaluation.
    Sturesson LW; Frennström JO; Ilardi M; Reinstrup P
    Eur J Anaesthesiol; 2015 Aug; 32(8):521-6. PubMed ID: 25387299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile sedation with sevoflurane in intensive care patients with acute stroke or subarachnoid haemorrhage using AnaConDa®: an observational study.
    Purrucker JC; Renzland J; Uhlmann L; Bruckner T; Hacke W; Steiner T; Bösel J
    Br J Anaesth; 2015 Jun; 114(6):934-43. PubMed ID: 25823541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of inhalational anaesthetic agents in paediatric and adult patients for status asthmaticus, status epilepticus and difficult sedation scenarios: a protocol for a systematic review.
    Gorsky K; Cuninghame S; Chen J; Jayaraj K; Withington D; Francoeur C; Slessarev M; Jerath A
    BMJ Open; 2021 Nov; 11(11):e051745. PubMed ID: 34758996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.